行情中心升级到1.1版! 官方博客

基金业绩

基金费率

投资组合

基金概况

财务数据

华夏医疗健康混合A(000945)

2025-12-31     1.7120-0.2331%
十大重仓股
截止日期:  
 查询其他基金该项数据
报表日期2025-09-30
序号 证券代码 证券简称 市值(万元) 数量(万股) 占基金净值比例(%) 其它基金持有(家)
1600276恒瑞医药9,857.88137.788.871273
2000963华东医药6,722.45161.796.0590
3300765新诺威6,199.55135.015.5886
4002294信立泰5,255.0287.084.73137
5688266泽璟制药4,730.6141.864.26225
6002422科伦药业4,676.46127.324.21168
7600079人福医药4,663.78221.244.20133
8688331荣昌生物4,489.6138.414.04174
9688382益方生物4,359.91140.143.92171
10688506百利天恒4,252.8611.333.83226
报表日期2025-06-30
序号 证券代码 证券简称 市值(万元) 数量(万股) 占基金净值比例(%) 其它基金持有(家)
1600276恒瑞医药8,243.57158.847.542796
2300765新诺威6,129.80118.595.60715
3000963华东医药6,013.71149.005.501109
4688266泽璟制药5,646.6952.525.161182
5002294信立泰4,876.21103.034.46864
6002422科伦药业4,856.38135.204.441205
7688428诺诚健华4,548.18186.174.16351
8600079人福医药4,119.52196.353.77853
9688617惠泰医疗3,716.9012.513.40974
10688382益方生物3,705.89112.923.39675
报表日期2025-03-31
序号 证券代码 证券简称 市值(万元) 数量(万股) 占基金净值比例(%) 其它基金持有(家)
1600276恒瑞医药8,243.57158.847.542796
2300765新诺威6,129.80118.595.60715
3000963华东医药6,013.71149.005.501109
4688266泽璟制药5,646.6952.525.161182
5002294信立泰4,876.21103.034.46864
6002422科伦药业4,856.38135.204.441205
7688428诺诚健华4,548.18186.174.16351
8600079人福医药4,119.52196.353.77853
9688617惠泰医疗3,716.9012.513.40974
10688382益方生物3,705.89112.923.39675